Enteric Disease Testing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

Enteric Disease Testing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2021-2026

  • September 2021 •
  • 147 pages •
  • Report ID: 5981472 •
  • Format: PDF
The global enteric disease testing market reached a value of US$ 3.87 Billion in 2020. Looking forward, the analyst expects the market to exhibit stable growth during 2021-2026. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.

Enteric diseases are caused by the entering of microorganisms, such as viruses, bacteria and parasites, in the body through the mouth. These pathogens can be acquired through contaminated food and water or by encountering feces of an animal or infected person. The common symptoms of enteric diseases are abdominal cramps, vomiting, nausea and anorexia that can lead to loss of fluids and essential nutrients from the body. In recent years, advancements in diagnostic technologies have revolutionized enteric disease testing and significantly increased the detection rates in symptomatic individuals.

The improper drainage and sanitation systems, unsafe drinking water and unhygienic living conditions can significantly increase the risk of enteric diseases. This, along with a substantial rise in medical tourism in recent years, represents one of the key factors impelling the market growth. Besides this, the increasing awareness among individuals about the benefits of early diagnosis is acting as another major growth-inducing factor. Apart from this, several international agencies, such as the World Health Organization (WHO) and the United Nations Children’s Fund (UNICEF), are conducting awareness programs and setting up healthcare camps in different countries to promote the testing of enteric diseases. Moreover, several key players are focusing on the commercialization of novel testing technologies, which is contributing to the market growth. Furthermore, as human coronaviruses cases are associated with enteric diseases, several healthcare institutes are conducting studies to find interrelation between enteric disease and the coronavirus disease (COVID-19).

Key Market Segmentation:
the analyst provides an analysis of the key trends in each sub-segment of the global enteric disease testing market, along with forecasts at the global, regional and country level from 2021-2026. Our report has categorized the market based on region, product type, technique, disease type and end-user.

Breakup by Product Type:
Reagents and Consumables
Equipment

Breakup by Technique:
Molecular Diagnostics
Immunodiagnostics

Breakup by Disease Type:
Bacterial Enteric Disease
C. Difficile
Campylobacteriosis
Cholera
E. Coli
H. Pylori
Salmonellosis
Shigellosis
Viral Enteric Disease
Rotavirus
Norovirus
Others
Parasitic Enteric Disease
Amebiasis
Cryptosporidiosis
Giardiasis

Breakup by End User:
Hospital Diagnostic Laboratories
Independent Diagnostic Laboratories
Academic and Research Institutes
Others

Breakup by Region:
North America
United States
Canada
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Latin America
Brazil
Mexico
Others
Middle East and Africa

Competitive Landscape:
The report has also analysed the competitive landscape of the market with some of the key players being Abbott Laboratories, BD (Becton, Dickinson and Company), Bio-Rad Laboratories Inc., Biomerica Inc., Biomérieux SA, Cepheid Inc. (Danaher Corporation), Coris BioConcept, DiaSorin, Meridian Bioscience Inc. and Quest Diagnostics. Key Questions Answered in This Report:
How has the global enteric disease testing market performed so far and how will it perform in the coming years?
What are the key regional markets?
What has been the impact of COVID-19 on the global enteric disease testing market?
What is the breakup of the market based on the product type?
What is the breakup of the market based on the technique?
What is the breakup of the market based on the disease type?
What is the breakup of the market based on the end user?
What are the various stages in the value chain of the industry?
What are the key driving factors and challenges in the industry?
What is the structure of the global enteric disease testing market and who are the key players?
What is the degree of competition in the industry?